A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected ...

Key takeaways Cholesterol regulation and neuronal vulnerability: The study found that neurons in the locus coeruleus (LC)—a ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

CRISPR revealed new genes that may influence Parkinson's disease risk. (Science) The Alzheimer's Disease Research Center and ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Eisai Co.’s breakthrough Alzheimer’s drug Leqembi was cleared for use in the European Union, after the medicine was approved ...

An Ozarks doctor recently returned from presenting at a major international Alzheimer’s disease conference in Vienna, Austria ...

A California woman was motivated to embark on a 3,000-mile walk to raise awareness of the power of healthy living. Judy ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease Research Center. The center’s brain bank is preserving more than 4,000 ...